Amoy Diagnostics Co., Ltd. (SHE:300685)
China flag China · Delayed Price · Currency is CNY
17.35
+0.02 (0.12%)
Sep 1, 2026, 3:04 PM CST

Amoy Diagnostics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,1671,1871,1041,034832.43908.12
Other Revenue
10.3910.394.649.999.758.91
1,1781,1981,1091,044842.18917.03
Revenue Growth
2.83%8.01%6.27%23.91%-8.16%25.90%
Cost of Revenue
219.31219.19181.34176.92153.44147.19
Gross Profit
958.43978.54927.61866.58688.74769.84
Selling, General & Admin
365.96396.29418.83384.71360.44364.31
Research & Development
178.24177.59216.11203.22174.53156.12
Other Operating Expenses
9.2711.44.664.073.144.18
Operating Expenses
559.48592.86650.35597.12545.1534.79
Operating Income
398.95385.68277.25269.46143.64235.05
Interest Expense
-1.93-1.93-1.34-1.2-0.99-0.38
Interest & Investment Income
40.1939.7626.5819.176.115.59
Currency Exchange Gain (Loss)
-6.85-6.852.428.2525.32-9.48
Other Non Operating Income (Expenses)
-64.94-19.08-18.45-0.33-2.08-0.48
EBT Excluding Unusual Items
365.42397.58286.46295.35171.99230.3
Gain (Loss) on Sale of Investments
0.010.71-8.71-15.691.985.85
Gain (Loss) on Sale of Assets
0.540.49-1.06-0.9694.58-1.96
Asset Writedown
-2.87-2.84-0.06-0.04-0.61-0.27
Other Unusual Items
14.9914.9913.2616.1918.1518.06
Pretax Income
378.09410.92289.88294.86286.08251.98
Income Tax Expense
39.7549.6735.0233.3721.7912.95
Earnings From Continuing Operations
338.34361.26254.86261.48264.29239.02
Minority Interest in Earnings
-----0.550.55
Net Income
338.34361.26254.86261.48263.74239.57
Net Income to Common
338.34361.26254.86261.48263.74239.57
Net Income Growth
12.76%41.74%-2.53%-0.86%10.09%32.86%
Shares Outstanding (Basic)
398397398396394399
Shares Outstanding (Diluted)
402401398396394399
Shares Change
1.75%0.80%0.51%0.65%-1.41%-0.36%
EPS (Basic)
0.850.910.640.660.670.60
EPS (Diluted)
0.840.900.640.660.670.60
EPS Growth
10.83%40.63%-3.03%-1.49%11.67%33.33%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
328.46294.6301.64253.8570.7593.61
Free Cash Flow Per Share
0.820.730.760.640.180.23
Dividend Per Share
0.4500.4500.3000.1500.1400.128
Dividend Growth
50.00%50.00%100.00%7.14%9.55%-7.99%
Gross Margin
81.38%81.70%83.65%83.05%81.78%83.95%
Operating Margin
33.87%32.20%25.00%25.82%17.06%25.63%
Profit Margin
28.73%30.16%22.98%25.06%31.32%26.13%
Free Cash Flow Margin
27.89%24.60%27.20%24.33%8.40%10.21%
EBITDA
440.63429.88329.31322.24191.46271.49
EBITDA Margin
37.41%35.89%29.70%30.88%22.73%29.61%
D&A For EBITDA
41.6944.252.0552.7847.8236.45
EBIT
398.95385.68277.25269.46143.64235.05
EBIT Margin
33.87%32.20%25.00%25.82%17.06%25.63%
Effective Tax Rate
10.51%12.09%12.08%11.32%7.62%5.14%
Revenue as Reported
1,1781,1981,1091,044842.18917.03